title: [Therapeutics of infection by Helicobacter pylori in 2008].
abstract: Eradication therapy for Helicobacter pylori is recommended in a number of clinical conditions as developed in Maastricht Consensus (I, II, III). In this state of art we discuss the results of current eradication therapies, the new approaches to the management of infection (new antibiotics and eradication schemes) and antimicrobial resistance.
authors: Unidad de Esófago y Estómago, Hospital de Gastroenterología Dr. Carlos Bonorino Udaondo, Facultad de Medicina, Universidad de Buenos Aires, Argentina. rodolfocorti@hotmail.com
authors: Rodolfo
authors: R
authors: Corti
authors: Judith
authors: J
authors: Doweck
authors: Liliana
authors: L
authors: Schenone
authors: Rafael
authors: R
authors: Améndola
authors: Adriana
authors: A
authors: Giordano Romano
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D024881:Drug Resistance, Bacterial; D004359:Drug Therapy, Combination; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000187:drug effects; D006801:Humans
chemical_list: D000900:Anti-Bacterial Agents